Special Issue "The Involvement of Cholinergic and Norepinephrine Network Modulation in Alzheimer’s Disease Cognitive Dysfunction"
Deadline for manuscript submissions: 31 October 2021.
Interests: Clinical Neurology; Alzheimer’s disease; Parkinson disease; Parkinson-related disease; Cognitive dysfunction; Neurobiology; Neurophysiology; Neuroprotection; Neurorehabilitation; Neuroradiology
Interests: Neurophysiology; Neurobiology; Molecular biology; Oligodendrocyte; Microglia; Neural network; Clinical Neurology
Some people can tolerate more Alzheimer’s-related pathological change, senile plagues, and neurofibrillary tangles than others, due to having a “cognitive reserve.” In individuals with cognitive reserve, the functional network connection in the cerebral cortex can be visualized as intact using functional Magnetic Resonance Imaging. However, the details of the molecular mechanism underlying the prevention of cognitive impairment in the presence of AD-related pathology are still unknown. Interestingly, the cholinergic and/or adrenergic neural signaling may modulate hippocampal glutamatergic neural activity under the AD-related pathology. In this Special Issue, we are seeking novel research and/or review articles on:
- The pathological condition and cognitive dysfunction
- The advancement of AD model animal from a standpoint of neural network
- Neurophysiological network and/or modulation
- Prevention of impairment in cognition/neural network under AD-related pathology
- Functional Magnetic Resonance Imaging and neural network
In this issue, we are looking for articles clearly articulating the molecular and/or physiological mechanism underlying cognitive reserve in patients with AD-related pathology.
Dr. Noriyuki Matsukawa
Dr. Daisuke Kato
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Alzheimer’s disease
- Cognitive dysfunction
- Neural modulation
- Cholinergic neural signaling
- Norepinephrine neural signaling
- Functional imaging